Search Results 1841-1850 of 20465 for hepatitis

1. Evaluate REC-4881 in Patients With FAP (TUPELO) - Mayo Clinic

   Active or known HIV, hepatitis B or hepatitis C infections. 21. Has a severe or uncontrolled medical condition. 22. Use of strong BCRP or MRP2 inhibitors ...

2. Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery - Mayo Clinic

   Known history of human immunodeficiency virus (HIV) infection, active infection with hepatitis B virus or hepatitis C virus, or any uncontrolled active systemic ...

3. A Study to Evaluate the Safety and Effectiveness of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy - Mayo Clinic

   ... hepatitis B or hepatitis C. Subjects who have exhibited allergic reactions to tipifarnib or structural compounds similar to tipifarnib or to its excipients ...

4. General Internal Medicine - Doctors - Mayo Clinic

   Horsley, M.D.. Internist. Phoenix, AZ. Areas of focus: LGBT health care, Sexual dysfunction, Hepatitis C, Hepatitis B, HIV/AIDS, Erectile dysfunction, Sexually ...

5. A Study to Evaluate Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC - Mayo Clinic

   Active infection including tuberculosis, hepatitis B, hepatitis C, or human immunodeficiency virus (HIV). History of allogenic organ transplantation. Known ...

6. A Study to Investigate the Effectiveness and Safety of Efgartigimod Ph20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy - Mayo Clinic

   ... Hepatitis B virus (HBV); Hepatitis C virus (HCV); HIV * Participant has previously participated in an efgartigimod clinical trial and received at least 1 ...

7. Spearhead 1 Study In Subjects With Advanced Synovial Sarcoma Or Myxoid/Round Cell Liposarcoma - Mayo Clinic

   * Active infection with human immunodeficiency virus, hepatitis B virus, hepatitis C virus, or human T cell leukemia virus * Pregnant or breastfeeding. Note ...

8. A Study to Evaluate the Safety and Effectiveness of Intratumoral and Intravenous Injection of Vesicular Stomatitis Virus Expressing Human Interferon Beta, and Tyrosinase Related Protein 1 (VSV-IFNb-TYRP1) in Patients with Metastatic Ocular Melanoma and Previously Treated Patients with Unresectable Stage III/IV Cutaneous Melanoma - Mayo Clinic

   Known acute or chronic hepatitis B or hepatitis C infection (requires negative test). Metastatic ocular melanoma patients only: liver radioembolization ...

9. DISC-3405 In Participants With Polycythemia Vera - Mayo Clinic

   Active human immunodeficiency virus (HIV), hepatitis B or C. A positive hepatitis or HIV result should be discussed between the Investigator and Sponsor prior ...

10. A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma - Mayo Clinic

    Patients with Hepatitis B are eligible provided there is no active viral replication. Patients with Hepatitis C who are not on interferon are eligible.